New stent graft registry aims to track safety in real patients
NCT ID NCT07279649
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This registry is following 240 people who receive the GORE VIABAHN VBX stent graft to treat blocked or damaged arteries in the abdomen, pelvis, or limbs. Researchers are tracking how well the device works and any serious side effects over time. The goal is to see if the stent graft performs safely in everyday medical practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- GORE VIABAHN VBX balloon expandable stent graft
- What this could lead to
- If successful, this registry could confirm that the VBX stent graft is safe and effective for treating blocked or damaged arteries in routine practice.
- What could go wrong
- This is an observational registry, not a controlled trial, so results may be influenced by patient selection and site practices. It does not compare the device to other treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTO-ILIAC OCCLUSIVE DISEASE (AIOD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
TUM Klinikum
RECRUITINGMunich, 81675, Germany